Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Urology - Original Paper

Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study

Authors: Kemal Ener, Murat Keske, Mustafa Aldemir, Muhammet Fuat Özcan, Emrah Okulu, Asım Özayar, Merve Ergin, Ömer Gökhan Doluoğlu, Serdar Çakmak, Özcan Erel

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

Purpose

This study aimed to investigate oxidative stress in etiopathogenesis by analyzing serum total antioxidant capacity (TAC), total oxidant status (TOS), binding capacity of exogenous cobalt to human albumin (IMA), serum advanced oxidation protein products (AOPP), paraoxonase (PON), arylesterase, IgE, and C-reactive protein (CRP) in bladder pain syndrome/interstitial cystitis (BPS/IC).

Methods

The study included 16 female patients diagnosed with BPS/IC and 25 healthy female subjects forming the control group. A bladder biopsy was performed on all patients in the BPS/IC group by carrying out cystoscopy with hydrodistention under general anesthesia. The results of serum TAC, TOS, IMA, AOPP, PON, arylesterase, IgE, and CRP of the subjects in both groups were compared.

Results

The mean age of the 16 female patients in the BPS/IC group was 43.6 ± 14.5 years, and the mean age of the 25 healthy subjects in the control group was 42.0 ± 10.3 years. According to the criteria of International Society for the Study of Interstitial Cystitis (ESSIC), eight patients were classified as Type 2A, three patients as Type 2B, four patients as Type 2C, and one patient as Type 3C. In the BPS/IC group, while TAC was found significantly lower than in the control group, IMA, IgE, and CRP were found significantly higher (P < 0.05). When binary logistic regression analysis was performed, the created model was determined to have 81.3 % sensitivity and 80 % specifity.

Conclusions

In the etiology of BPS/IC, mechanism of oxidative damage comes into prominence. In the diagnosis of BPS/IC, IgE, CRP, and TAC are not specific markers when used separately; however, a higher specifity and sensitivity could be reached when used jointly in the suspected patients.
Literature
1.
Fal M, Johansson SL, Aldenborg F (1987) Chronic interstitial cystitis: a heterogeneous syndrome. J Urol 137(1):35–38
2.
van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK et al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53(1):60–67PubMedCrossRef
3.
Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, Moon TD et al (1999) Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in theurine of interstitial cystitis and bladder cancer patients. J Urol 161(2):438–441PubMedCrossRef
4.
Nickel JC, Shoskes DA, Irvine-Bird K (2010) Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful bladder syndrome. Urology 76(4):799–803PubMedCrossRef
5.
Talati A, Ponniah K, Strug LJ, Hodge SE, Fyer AJ, Weissman MM (2008) Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biol Psychiatry 63(6):594–601PubMedCentralPubMedCrossRef
6.
Malone L, Schuler C, Leggett RE, Levin RM (2014) Effect of estrogen and ovariectomy on response of the female rabbit urinary bladder to two forms of in vitro oxidative stres. Int Urogynecol J 25(6):791–798PubMedCrossRef
7.
Gutteridge JM, Halliwell B (2000) Free radicals and antioxidants in the year 2000: a historical look to the future. Ann N Y Acad Sci 899:136–147PubMedCrossRef
8.
Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277–285PubMedCrossRef
9.
Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12):1103–1111PubMedCrossRef
10.
Camps J, Marsillach J, Joven J (2009) The paraoxonase: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106PubMedCrossRef
11.
Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP et al (2010) Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact 187(1–3):355–361PubMedCentralPubMedCrossRef
12.
James RW (2006) A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin Chem Lab Med 44:1052–1059PubMedCrossRef
13.
Novak F, Vavrova L, Kodydkova J, Novak F Sr, Hynkova M, Zak A et al (2010) Decreased paraoxonase activity in critically ill patients with sepsis. Clin Exp Med 10:21–25PubMedCrossRef
14.
Bar-Or D, Lau E, Winkler JV (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia—a preliminary report. J Emerg Med 19(4):311–315PubMedCrossRef
15.
Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M (1997) Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J Mol Cell Cardiol 29:3025–3034PubMedCrossRef
16.
Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillère-Blandin C, Nguyen AT, Canteloup S et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161(5):2524–2532PubMed
17.
Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T et al (2010) Bladder pain syndrome committee of the international consultation on incontinence. Neurourol Urodyn 29(1):191–198PubMedCrossRef
18.
Eckerson HW, Wyte CM, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35(6):1126–1138PubMedCentralPubMed
19.
Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 30(7):391–395
20.
Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49(5):1304–1313PubMedCrossRef
21.
Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M (2006) Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study. Eur Urol 49(4):704–709PubMedCrossRef
22.
Palmieri K, Mannikarottu AS, Chichester P, Kogan B, Leggett RE, Whitbeck C et al (2007) The effects of cyclical oestrogen on bladder and urethral structure and function. BJU Int 99(1):171–176PubMedCrossRef
23.
Rehfuss A, Schuler C, Maxemous C, Leggett RE, Levin RM (2010) Cyclical estrogen and free radical damage to the rabbit urinary bladder. Int Urogynecol J 21(4):489–494PubMedCrossRef
24.
Badger WJ, Whitbeck C, Kogan B, Chichester P, Levin RM (2006) The immediate effect of castration on female rabbit bladder blood flow and tissue oxygenation. Urol Int 76:264–268PubMedCrossRef
25.
Bae WJ, Ha US, Kim S, Kim SJ, Hong SH, Lee JY et al (2015) Reduction of oxidative stress may play a role in the anti-inflammatory effect of the novel herbal formulation in a rat model of hydrochloric acid-induced cystitis. Neurourol Urodyn 34(1):86–91PubMedCrossRef
26.
Ehrén I, Hosseini A, Lundberg JO, Wiklund NP (1999) Nitric oxide: a useful gas in the detection of lower urinary tract inflammation. J Urol 162(2):327–329PubMedCrossRef
27.
Birder LA, Wolf-Johnston A, Buffington CA, Roppolo JR, de Groat WC, Kanai AJ (2005) Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 173(2):625–629PubMedCrossRef
28.
Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL et al (2004) Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 43(4):629–634PubMedCrossRef
29.
Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama J, Miyagawa Y et al (2009) Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int 104(6):826–831PubMedCrossRef
30.
Lee J, Doggweiler-Wiygul R, Kim S, Hill BD, Yoo TJ (2006) Is interstitial cystitis an allergic disorder? A case of interstitial cystitis treated successfully with anti-IgE. Int J Urol 13(5):631–634PubMedCrossRef
31.
Boucher W, Kempuraj D, Cao J, Papaliodis D, Theoharides TC (2007) Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation. J Urol 177(3):1186–1190PubMedCrossRef
32.
Kaneko G, Nishimoto K, Ito Y, Uchida A (2012) The combination therapy of prednisolone and tacrolimus for severe painful bladder syndrome/interstitial cystitis. Can Urol Assoc J 6(2):E46–E49PubMedCentralPubMedCrossRef
33.
Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M et al (2000) Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol 164(6):2119–2125PubMedCrossRef
34.
Giannantoni A, Bini V, Dmochowski R, Hanno P, Nickel JC, Proietti S et al (2012) Contemporary management of the painful bladder: a systematic review. Eur Urol 61(1):29–53PubMedCrossRef
35.
Zeybek A, Sağlam B, Cikler E, Cetinel S, Ercan F, Sener G (2007) Taurine ameliorates stress-induced degeneration of the urinary bladder. Acta Histochem 109(3):208–214PubMedCrossRef
36.
Zhang QH, Zhou ZS, Lu GS, Song B, Guo JX (2013) Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats. Inflammation 36(3):651–657PubMedCrossRef
37.
Bazi T, Hajj-Hussein IA, Awwad J, Shams A, Hijaz M, Jurjus A (2013) A modulating effect of epigallocatechin gallate (EGCG), a tea catechin, on the bladder of rats exposed to water avoidance stress. Neurourol Urodyn 32(3):287–292PubMedCrossRef
Metadata
Title
Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study
Authors
Kemal Ener
Murat Keske
Mustafa Aldemir
Muhammet Fuat Özcan
Emrah Okulu
Asım Özayar
Merve Ergin
Ömer Gökhan Doluoğlu
Serdar Çakmak
Özcan Erel
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1021-1

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue

Urology - Original Paper

Effect of medical expulsive therapy on the health-related quality of life of patients with ureteral stones: a critical evaluation

Urology - Original Paper

Intestinal seromuscular tunneling: a novel method for ureteral replacement—an experimental design

Nephrology - Original Paper

Outcomes following renal transplantation in older renal transplant recipients: a single-center experience and “Croatian senior program”

Urology - Original Paper

Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?

Urology - Original Paper

Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy

Nephrology - Letter to the Editor

Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits